An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia

Am J Hematol. 2021 Jan;96(1):E17-E20. doi: 10.1002/ajh.26012. Epub 2020 Oct 23.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aftercare
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Clinical Decision-Making*
  • Cytarabine / administration & dosage
  • Databases, Factual*
  • Disease-Free Survival
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / mortality
  • Male
  • Middle Aged
  • Survival Rate

Substances

  • Cytarabine
  • Idarubicin